MedPath

Efficacy of combined thoracic paravertebral block and intravenous dexmedetomidine in medical thoracoscopy

Phase 4
Recruiting
Conditions
Circulatory System
Respiratory
Registration Number
PACTR202005777730971
Lead Sponsor
Ayman Maaly
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Patients indicated for medical thoracoscopy
ASA I and II
Aged 25-55 years
No history of allergy to any of the used drugs.

Exclusion Criteria

ASA III and IV
Aged below 25 or above 55 years
History of allergy to any of the used drugs.
Uncooperative patient
Severe musculoskeletal abnormalities
Patients with coagulopathy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath